Eli Lilly targets alleged black market sales of its experimental GLP-1 drug
Eli Lilly targets alleged black market sales of its experimental GLP-1 drug
5.8Significance
2 sources7.0Source trust
Top stories · Organization
Eli Lilly targets alleged black market sales of its experimental GLP-1 drug